At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable New York and New Jersey State regulatory authorities, COVID-19 vaccination (2 doses of either the Pfizer or Moderna vaccine or one dose of the Johnson & Johnson vaccine) is mandatory for all MSK employees, contingent workers, and volunteers. Exceptions are permitted for those employees who request and receive an approved medical or fully remote exemption.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster five months after receiving the second dose of either the Pfizer or Moderna vaccine or two months after the J&J vaccine.
The Memorial Sloan-Kettering Cancer Center (MSKCC) section of Dermatology is seeking a full time Mohs dermatologic surgeon to join a busy academic dermatology practice based primarily in our Hauppauge regional site, specialized in the diagnosis and management of skin cancer. Applicants must have expertise in Mohs micrographic surgery and an interest in clinical research and teaching. Opportunities for multidisciplinary clinical research and collaborative projects are numerous.
Memorial Sloan Kettering Cancer Center (MSK) is one of the world's premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything they do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers. MSK ranks in the top 20 on Forbes' list of America's best employers for diversity.
The MSK Dermatology Service has a renowned faculty and a robust research program in the areas of optical imaging, medical informatics, artificial intelligence, patient reported outcomes, clinical trials, and epidemiologic studies.
An M.D., M.D./Ph.D., D.O. or equivalent with excellent clinical, communication and team skills.
Board certification in Dermatology by American Board of Dermatology.
MDS (Micrographic Dermatologic Surgery) subspecialty certification or eligibility for certification by ABD.
ACGME MSDO fellowship successful completion.
Licensure in the state of New York, or eligibility for a medical license in New York required.
A track record of academic productivity.
Strong potential for research independence.
Please send CV, a letter outlining your interest in the position, a statement of career interests and goals, and names/contact information of at least three references to: Melissa Paz, email@example.com
Compensation arrangements are competitive and commensurate with both experience and achievement. Applications will be reviewed on a rolling basis until the position is filled.
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.